Cargando…

RASSF6; the Putative Tumor Suppressor of the RASSF Family

Humans have 10 genes that belong to the Ras association (RA) domain family (RASSF). Among them, RASSF7 to RASSF10 have the RA domain in the N-terminal region and are called the N-RASSF proteins. In contradistinction to them, RASSF1 to RASSF6 are referred to as the C-RASSF proteins. The C-RASSF prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwasa, Hiroaki, Jiang, Xinliang, Hata, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695899/
https://www.ncbi.nlm.nih.gov/pubmed/26690221
http://dx.doi.org/10.3390/cancers7040899
_version_ 1782407716000497664
author Iwasa, Hiroaki
Jiang, Xinliang
Hata, Yutaka
author_facet Iwasa, Hiroaki
Jiang, Xinliang
Hata, Yutaka
author_sort Iwasa, Hiroaki
collection PubMed
description Humans have 10 genes that belong to the Ras association (RA) domain family (RASSF). Among them, RASSF7 to RASSF10 have the RA domain in the N-terminal region and are called the N-RASSF proteins. In contradistinction to them, RASSF1 to RASSF6 are referred to as the C-RASSF proteins. The C-RASSF proteins have the RA domain in the middle region and the Salvador/RASSF/Hippo domain in the C-terminal region. RASSF6 additionally harbors the PSD-95/Discs large/ZO-1 (PDZ)-binding motif. Expression of RASSF6 is epigenetically suppressed in human cancers and is generally regarded as a tumor suppressor. RASSF6 induces caspase-dependent and -independent apoptosis. RASSF6 interacts with mammalian Ste20-like kinases (homologs of Drosophila Hippo) and cross-talks with the Hippo pathway. RASSF6 binds MDM2 and regulates p53 expression. The interactions with Ras and Modulator of apoptosis 1 (MOAP1) are also suggested by heterologous protein-protein interaction experiments. RASSF6 regulates apoptosis and cell cycle through these protein-protein interactions, and is implicated in the NF-κB and JNK signaling pathways. We summarize our current knowledge about RASSF6 and discuss what common and different properties RASSF6 and the other C-RASSF proteins have.
format Online
Article
Text
id pubmed-4695899
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-46958992016-01-19 RASSF6; the Putative Tumor Suppressor of the RASSF Family Iwasa, Hiroaki Jiang, Xinliang Hata, Yutaka Cancers (Basel) Review Humans have 10 genes that belong to the Ras association (RA) domain family (RASSF). Among them, RASSF7 to RASSF10 have the RA domain in the N-terminal region and are called the N-RASSF proteins. In contradistinction to them, RASSF1 to RASSF6 are referred to as the C-RASSF proteins. The C-RASSF proteins have the RA domain in the middle region and the Salvador/RASSF/Hippo domain in the C-terminal region. RASSF6 additionally harbors the PSD-95/Discs large/ZO-1 (PDZ)-binding motif. Expression of RASSF6 is epigenetically suppressed in human cancers and is generally regarded as a tumor suppressor. RASSF6 induces caspase-dependent and -independent apoptosis. RASSF6 interacts with mammalian Ste20-like kinases (homologs of Drosophila Hippo) and cross-talks with the Hippo pathway. RASSF6 binds MDM2 and regulates p53 expression. The interactions with Ras and Modulator of apoptosis 1 (MOAP1) are also suggested by heterologous protein-protein interaction experiments. RASSF6 regulates apoptosis and cell cycle through these protein-protein interactions, and is implicated in the NF-κB and JNK signaling pathways. We summarize our current knowledge about RASSF6 and discuss what common and different properties RASSF6 and the other C-RASSF proteins have. MDPI 2015-12-09 /pmc/articles/PMC4695899/ /pubmed/26690221 http://dx.doi.org/10.3390/cancers7040899 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Iwasa, Hiroaki
Jiang, Xinliang
Hata, Yutaka
RASSF6; the Putative Tumor Suppressor of the RASSF Family
title RASSF6; the Putative Tumor Suppressor of the RASSF Family
title_full RASSF6; the Putative Tumor Suppressor of the RASSF Family
title_fullStr RASSF6; the Putative Tumor Suppressor of the RASSF Family
title_full_unstemmed RASSF6; the Putative Tumor Suppressor of the RASSF Family
title_short RASSF6; the Putative Tumor Suppressor of the RASSF Family
title_sort rassf6; the putative tumor suppressor of the rassf family
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695899/
https://www.ncbi.nlm.nih.gov/pubmed/26690221
http://dx.doi.org/10.3390/cancers7040899
work_keys_str_mv AT iwasahiroaki rassf6theputativetumorsuppressoroftherassffamily
AT jiangxinliang rassf6theputativetumorsuppressoroftherassffamily
AT hatayutaka rassf6theputativetumorsuppressoroftherassffamily